Considerations on the use of urine markers for bladder cancer

被引：6
|
作者：
van Rhijn, Bas W. G. [1 ]
机构：
[1] Univ Toronto, Dept Surg, Div Urol, Univ Hlth Network, Toronto, ON M5G 2M9, Canada
来源：
EUROPEAN UROLOGY | 2008年 / 53卷 / 05期
关键词：
D O I：
10.1016/j.eururo.2008.01.043
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：880 / 881
页数：2
相关论文
共 50 条
  • [1] Considerations on the use of diagnostic markers in management of patients with bladder cancer
    Piyush K. Agarwal
    Peter C. Black
    Ashish M. Kamat
    World Journal of Urology, 2008, 26 : 39 - 44
  • [2] Considerations on the use of diagnostic markers in management of patients with bladder cancer
    Agarwal, Piyush K.
    Black, Peter C.
    Kamat, Ashish M.
    WORLD JOURNAL OF UROLOGY, 2008, 26 (01) : 39 - 44
  • [3] Considerations on the use of urine markers in the management of with high-grade non-muscle-invasive bladder cancer
    Kamat, Ashish M.
    Vlahou, Antonia
    Taylor, John A.
    Hudson, M'Liss A.
    Pesch, Beate
    Ingersoll, Molly A.
    Todenhoefer, Tilmann
    van Rhijn, Bas
    Kassouf, Wassim
    Grossman, H. Barton
    Behrens, Thomas
    Chandra, Ashish
    Goebell, Peter J.
    Palou, Juan
    Sanchez-Carbayo, Marta
    Schmitz-Draeger, Bernd J.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2014, 32 (07) : 1069 - 1077
  • [4] Urine markers for detection and surveillance of bladder cancer
    Xylinas, Evanguelos
    Kluth, Luis A.
    Rieken, Malte
    Karakiewicz, Pierre I.
    Lotan, Yair
    Shariat, Shahrokh F.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2014, 32 (03) : 222 - 229
  • [5] Molecular prognostic markers of urine bladder cancer
    Pavlov, V. N.
    Izmailov, A. A.
    Akhmadishina, L. Z.
    Victorova, T. V.
    Izmailova, S. M.
    Urmantsev, M. F.
    Alekseev, A. V.
    Zagitov, A. R.
    Kutliyarov, L. M.
    ONKOUROLOGIYA, 2012, 8 (02): : 32 - 36
  • [6] Urine cytology, tumour markers and bladder cancer
    Halachmi, S
    Linn, JF
    Amiel, GE
    Moskovitz, B
    Nativ, O
    BRITISH JOURNAL OF UROLOGY, 1998, 82 (05): : 647 - 654
  • [7] Considerations on the use of urine markers in the management of patients with low-/intermediate-risk non-muscle invasive bladder cancer
    Schmitz-Draeger, Bernd J.
    Todenhoefer, Tilman
    van Rhijn, Bas
    Pesch, Beate
    Hudson, Mliss A.
    Chandra, Ashish
    Ingersoll, Molly A.
    Kassouf, Wassim
    Palou, Joan
    Taylor, John
    Vlahou, Antonia
    Behrens, Thomas
    Critelli, Rossana
    Grossman, H. Barton
    Sanchez-Carbayo, Marta
    Kamat, Ashish
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2014, 32 (07) : 1061 - 1068
  • [8] Urine markers for bladder cancer surveillance: A systematic review
    不详
    EUROPEAN UROLOGY SUPPLEMENTS, 2005, 4 (03) : 219 - 219
  • [9] Urine markers for bladder cancer surveillance: A systematic review
    van Rhijn, BWG
    van der Poel, HG
    van der Kwast, TH
    EUROPEAN UROLOGY, 2005, 47 (06) : 736 - 748
  • [10] Bladder cancer detection in urine by novel methylation markers
    Beijert, Irene J.
    Wever, Birgit M. M.
    Hentschel, Anouk E.
    van den Burgt, Yara
    Kauer, Paul C.
    Lissenberg-Witte, Birgit I.
    van Moorselaar, R. Jeroen A.
    Steenbergen, Renske D. M.
    Nieuwenhuijzen, Jakko A.
    SCIENTIFIC REPORTS, 2024, 14 (01):
12345